PALO ALTO, Calif., Feb. 4, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of ...
Feeds
6286 items (6286 unread) in 74 feeds
Acinar Cell Carcinoma
(36 unread)
Acinic Cell Carcinoma
(30 unread)
Adenoid Cystic Carcinoma
(92 unread)
Adrenal Gland Cancer
(549 unread)
Ampulla Of Vater
(102 unread)
Anal Cancer
(662 unread)
Angiosarcoma
(192 unread)
Appendix Cancer
(77 unread)
Bile Duct Cancer
(719 unread)
Brain and CNS
(854 unread)
Carcinoid
(273 unread)
Endocrine/Neuroendocrine
(727 unread)
Gall Bladder Cancer
(343 unread)
Hemangioendothelioma
(41 unread)
Hepatoblastoma
(121 unread)
Pancreas
(75 unread)
Phyllodes
(44 unread)
PMP and Mucinous Tumors
(62 unread)
Rhabdomyosarcoma
(234 unread)
Sarcoma
(1053 unread)
Google - Insulinoma (52 unread)
-
Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study of Avexitide in Post-Bariatric Hypoglycemia (PBH) at Upcoming Endocrine Society (ENDO) Meeting 2019 in New Orleans - PRNewswire
Posted: February 4th, 2019, 11:00am GMT
Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study of Avexitide in Post-Bariatric Hypoglycemia (PBH) at Upcoming Endocrine Society (ENDO) Meeting 2019 in New Orleans PRNewswire -
Global Insulinoma Market 2019 – Abcam plc, Cironpharma, Pfizer Plc, Entax Medical, Olympus, Boston Scientificrporation - The Concepts News
Posted: February 4th, 2019, 8:15am GMT
Global Insulinoma Market 2019 – Abcam plc, Cironpharma, Pfizer Plc, Entax Medical, Olympus, Boston Scientificrporation The Concepts NewsThe global “Insulinoma Market” report delivers a comprehensive and systematic framework of the Insulinoma market at a global level that includes all the key ...
-
Insulinoma Treatment Market Processing Equipment Productions Supply Sales Demand Market Status and Forecast 2019 To 2022 - Fashion Herald
Posted: February 2nd, 2019, 6:58pm GMT
Insulinoma Treatment Market Processing Equipment Productions Supply Sales Demand Market Status and Forecast 2019 To 2022 Fashion HeraldGlobal Insulinoma Treatment Market report focus on growth analysis and past & futuristic cost of Insulinoma Treatment industry. Insulinoma Treatment Market ...
-
Global Insulinoma Market 2019 – Takeda Pharmaceutical Co. Ltd., Vanda Pharmaceuticals, Merck & Co, Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd - The Concepts News
Posted: January 31st, 2019, 8:53am GMT
Global Insulinoma Market 2019 – Takeda Pharmaceutical Co. Ltd., Vanda Pharmaceuticals, Merck & Co, Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd The Concepts NewsGlobal Insulinoma Market research report delivers industry business trends and the enterprise data, accepting one to comprehend customers and the ...
-
Current Change: Controladora Vuela Compania De Aviacion SAB De CV Ten 10 Ordinary Participation Certificates (NYSE: VLRS) - Reagents Global Market
Posted: January 25th, 2019, 12:36am GMT
Current Change: Controladora Vuela Compania De Aviacion SAB De CV Ten 10 Ordinary Participation Certificates (NYSE: VLRS) Reagents Global MarketThe long-term trend of the EPS is an important number as it indicates the present value of Controladora Vuela Compania De Aviacion S.A.B. De C.V. Ten 10 Or.
-
Current Change: Towne Bank (NASDAQ: TOWN) - Reagents Global Market
Posted: January 25th, 2019, 12:35am GMT
Current Change: Towne Bank (NASDAQ: TOWN) Reagents Global MarketThe growth of the EPS is critical in understanding the current valuation of Towne Bank. It is typically displayed as a percentage and called the EPS growth.
-
Stock Watch: Xeris Pharmaceuticals (NASDAQ: XERS) - Reagents Global Market
Posted: January 25th, 2019, 12:35am GMT
Stock Watch: Xeris Pharmaceuticals (NASDAQ: XERS) Reagents Global MarketThe long-term trend of the EPS is a vital number as it helps understand the future potential of Xeris Pharmaceuticals. It is typically displayed as a perce.
-
The insulinoma treatment market will register a CAGR of over 4% by 2023 - PRNewswire
Posted: January 23rd, 2019, 7:05pm GMT
The insulinoma treatment market will register a CAGR of over 4% by 2023 PRNewswireLONDON, Jan. 23, 2019 /PRNewswire/ -- About this market Advances in laparoscopic treatment and diagnostic techniques have a considerable impact on the ...
-
Automotive Coatings Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 - PRNewswire
Posted: January 23rd, 2019, 7:05pm GMT
Automotive Coatings Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 PRNewswireLONDON, Jan. 23, 2019 /PRNewswire/ -- Automotive Coatings Market - Overview Automotive coatings are applied on the surface of automotive or vehicles to ...
-
Global Insulinoma Treatment Market Analysis & Outlook 2019-2023; Led by Ipsen Pharma, Johnson & Johnson, Novartis, Pfizer, and Teva Pharmaceutical Industries - ResearchAndMarkets.com - Associated Press
Posted: January 23rd, 2019, 11:08am GMT
Global Insulinoma Treatment Market Analysis & Outlook 2019-2023; Led by Ipsen Pharma, Johnson & Johnson, Novartis, Pfizer, and Teva Pharmaceutical Industries - ResearchAndMarkets.com Associated PressDUBLIN--(BUSINESS WIRE)--Jan 23, 2019--The “Global Insulinoma Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com's ...
-
Global Insulinoma Treatment Market Analysis & Outlook 2019-2023; Led by Ipsen Pharma, Johnson & Johnson, Novartis, Pfizer, and Teva Pharmaceutical Industries - ResearchAndMarkets.com - Business Wire
Posted: January 23rd, 2019, 10:13am GMT
Global Insulinoma Treatment Market Analysis & Outlook 2019-2023; Led by Ipsen Pharma, Johnson & Johnson, Novartis, Pfizer, and Teva Pharmaceutical Industries - ResearchAndMarkets.com Business WireDUBLIN--(BUSINESS WIRE)--The "Global Insulinoma Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
-
Global Insulinoma Market 2018-2023: Top Companies, Present Demand, Share, Size and Future Growth Trends, Driving Factor Analysis, Competition Status - Current News Magazine
Posted: January 20th, 2019, 8:19pm GMT
Global Insulinoma Market 2018-2023: Top Companies, Present Demand, Share, Size and Future Growth Trends, Driving Factor Analysis, Competition Status Current News MagazineInsulinoma Market Report 2018-2023 includes a comprehensive analysis of the current Market (Top 20 Countries). The report starts with the basic Insulinoma ...
-
Trading Results: Xeris Pharmaceuticals (NASDAQ: XERS) - Reagents Global Market
Posted: January 18th, 2019, 12:58am GMT
Trading Results: Xeris Pharmaceuticals (NASDAQ: XERS) Reagents Global MarketThe long-term trend of the EPS is a vital number as it helps understand the future potential of Xeris Pharmaceuticals. It is typically displayed as a perce.
-
Diabetes Before 40, Mental Health Stays Linked - WebMD
Posted: January 15th, 2019, 6:00am GMT
Diabetes Before 40, Mental Health Stays Linked WebMDAbout 37 percent of all hospitalization days in a new study's under-40 group were due to mental illness, the researchers noted. Mood and psychotic disorders ...
-
Recognizing the Symptoms of NETs - OncLive
Posted: January 11th, 2019, 1:39pm GMT
Recognizing the Symptoms of NETs OncLiveAn overview of the hormones responsible for the various symptoms that patients with neuroendocrine tumors (NETs) may experience and suggestions for ...
-
Pathology Conference: Surgical Pathology for the Practicing Pathologist (January) - Scottsdale January 14-19, 2019 - MD Linx
Posted: January 11th, 2019, 3:10am GMT
Pathology Conference: Surgical Pathology for the Practicing Pathologist (January) - Scottsdale January 14-19, 2019 MD LinxThis course presents a broad overview of many areas of surgical pathology and is presented by Harvard Medical School faculty and selected guest faculty with ...
-
Current Performance: Xeris Pharmaceuticals (NASDAQ: XERS) - Reagents Global Market
Posted: January 11th, 2019, 12:52am GMT
Current Performance: Xeris Pharmaceuticals (NASDAQ: XERS) Reagents Global MarketEPS growth is an important number as it indicates the future prospects of Xeris Pharmaceuticals. It is usually expressed as a percentage and is then referr.
-
Latest Valuation: Sonic Foundry - Ordinary Shares (NASDAQ: SOFO) - Reagents Global Market
Posted: January 11th, 2019, 12:52am GMT
Latest Valuation: Sonic Foundry - Ordinary Shares (NASDAQ: SOFO) Reagents Global MarketThe long-term trend of the EPS is a vital number as it helps understand the future potential of Sonic Foundry - Ordinary Shares. The EPS growth rate, as it.
-
Present Valuation: Yuma Energy (AMEX: YUMA) - Reagents Global Market
Posted: January 11th, 2019, 12:52am GMT
Present Valuation: Yuma Energy (AMEX: YUMA) Reagents Global MarketEPS growth is an important number as it indicates the future prospects of Yuma Energy. It is usually expressed as a percentage and is then referred to as t.
-
Importance of pancreas in the human body: Pancreatic Diseases - India Today
Posted: January 10th, 2019, 10:21am GMT
Importance of pancreas in the human body: Pancreatic Diseases India TodayPancreas is an organ that is located in the abdominal region of a human body and is a part of the digestive system of the body. It is situated in the upper left of ...
-
Importance of pancreas in the human body: Pancreatic Diseases - India Today
Posted: January 10th, 2019, 6:00am GMT
Importance of pancreas in the human body: Pancreatic Diseases India TodayPancreas is an organ that is located in the abdominal region of a human body and is a part of the digestive system of the body. It is situated in the upper left of ...
-
Importance of pancreas in the human body - NewsPatrolling
Posted: January 8th, 2019, 6:00am GMT
Importance of pancreas in the human body NewsPatrollingThe pancreas is an organ that is located in the abdominal region of a human body and is a part of the digestive system of the body. It is situated in the.
-
In situ graphene liquid cell-transmission electron microscopy study of | IJN - Dove Medical Press
Posted: January 7th, 2019, 6:00am GMT
In situ graphene liquid cell-transmission electron microscopy study of | IJN Dove Medical PressIn situ graphene liquid cell-transmission electron microscopy study of insulin secretion in pancreatic islet cells Emre Firlar,1,2 Meagan Ouy,1 Leigha Covnot,1 ...
-
Type 2 Diabetes Med Might Not Harm Bones After All - WebMD
Posted: January 3rd, 2019, 6:00am GMT
Type 2 Diabetes Med Might Not Harm Bones After All WebMDCanagliflozin (Invokana, Invokamet) is in a class of medications called SGLT-2 inhibitors. These drugs cause the kidneys to remove excess sugar from the blood ...
-
CT angiography as effective as invasive coronary angiography - Specialty Medical Dialogues
Posted: January 1st, 2019, 6:00am GMT
CT angiography as effective as invasive coronary angiography Specialty Medical DialoguesCoronary CT angiography, a less invasive and cost-saving technique, is non-inferior to the invasive coronary angiography in diagnostic value, according to ...
-
Kidney Disease Risk Tied to Sugar-Sweetened Drinks - WebMD
Posted: December 27th, 2018, 6:00am GMT
Kidney Disease Risk Tied to Sugar-Sweetened Drinks WebMDThe study of more than 3000 black men and women in Mississippi found that those who consumed the most soda, sweetened fruit drinks and water had a 61 ...
-
New drug cocktail could be the key to diabetes treatment - Information-Analytic Agency NEWS.am
Posted: December 21st, 2018, 6:00am GMT
New drug cocktail could be the key to diabetes treatment Information-Analytic Agency NEWS.amThe finding involved one drug that inhibits the enzyme dual specificity tyrosine-regulated kinase 1A (DYRK1A) and another that inhibits transforming growth ...
-
C-Path encouraged by FDA to move forward on type 1 diabetes biomarker initiative - EurekAlert
Posted: December 18th, 2018, 6:00am GMT
C-Path encouraged by FDA to move forward on type 1 diabetes biomarker initiative EurekAlertC-Path announced today that its Type 1 Diabetes Consortium has received a positive response to its Letter of Intent from the FDA detailing the its decision to ...
-
Genetic Risk Score for Type 1 Diabetes Predicts Progression of Disease - Diabetes In Control
Posted: December 8th, 2018, 6:00am GMT
Genetic Risk Score for Type 1 Diabetes Predicts Progression of Disease Diabetes In ControlStudy focuses on score accuracy to improve prediction models for the better. Identifying patients at risk for developing type 1 diabetes (T1D) can allow for ...
-
Medical Mystery: What caused young athlete's recurring 'absence' seizures? - Philly.com
Posted: November 16th, 2018, 6:00am GMT
Medical Mystery: What caused young athlete's recurring 'absence' seizures? Philly.comIn the emergency room, clinicians drew blood and found the boy's blood sugar was dangerously low at 30 mg/dL (normal levels are 70 to 120). Why was his ...
-
Hypoglycemia - Contemporary Clinic
Posted: October 17th, 2018, 5:00am GMT
Hypoglycemia Contemporary ClinicHypoglycemia, also known as low blood sugar, can cause chills, clumsiness, and nightmares. For patients with diabetes, hypoglycemia can result from changes ...
-
Eiger BioPharmaceuticals Announces Positive Results in Phase 2 PREVENT Study of Avexitide Targeting GLP-1 in Post-Bariatric Hypoglycemia (PBH) - PR Newswire
Posted: October 16th, 2018, 5:00am GMT
Eiger BioPharmaceuticals Announces Positive Results in Phase 2 PREVENT Study of Avexitide Targeting GLP-1 in Post-Bariatric Hypoglycemia (PBH) PR NewswirePALO ALTO, Calif., Oct. 16, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of ...
-
Can Short Fasts Help Reverse Type 2 Diabetes? - WebMD
Posted: October 9th, 2018, 5:00am GMT
Can Short Fasts Help Reverse Type 2 Diabetes? WebMDA small study has showed that occasional 24-hour fasting regimens can significantly reverse or eliminate the need for diabetic medication.
-
Beta Bionics Awarded Up to $2 Million NIH Small Business Innovation Research (SBIR) Grant - GlobeNewswire
Posted: October 9th, 2018, 5:00am GMT
Beta Bionics Awarded Up to $2 Million NIH Small Business Innovation Research (SBIR) Grant GlobeNewswireAward from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Grant provides up to $2 million in funding over the next 24 months ...
-
Gene technology brings more precise information on the causes of diabetes - Medical Xpress
Posted: September 13th, 2018, 5:00am GMT
Gene technology brings more precise information on the causes of diabetes Medical XpressThe main cause of all forms of diabetes is pancreatic beta-cell dysfunction. Beta cells, found in the pancreatic islets, store and release insulin. Decades of ...
-
6 Hurricane Florence Preparation Tips for Diabetics - Everyday Health
Posted: September 13th, 2018, 5:00am GMT
6 Hurricane Florence Preparation Tips for Diabetics Everyday HealthHurricane Florence is headed toward the East Coast, and if you're in the storm's path, you're undoubtedly preparing for what could be a catastrophic weather ...
-
Melbourn Hub fundraiser for Meldreth woman with malignant insulinoma - Royston Crow
Posted: August 15th, 2018, 5:00am GMT
Melbourn Hub fundraiser for Meldreth woman with malignant insulinoma Royston CrowThe Melbourn Hub was abuzz during a cream tea fundraiser for a woman with a terminal illness.
-
Long Work Hours Linked to Higher Diabetes Risk in Women - Everyday Health, Inc.
Posted: July 10th, 2018, 5:00am GMT
Long Work Hours Linked to Higher Diabetes Risk in Women Everyday Health, Inc.July 10, 2018. Working overtime may help pay the bills, but it can be bad for your health. New research, published July 2 in BMJ Open Diabetes Research and ...
-
Even at 'Safe' Levels, Air Pollution May Boost Diabetes Risk - WebMD
Posted: June 29th, 2018, 5:00am GMT
Even at 'Safe' Levels, Air Pollution May Boost Diabetes Risk WebMDIn the study, the researchers estimated that air pollution contributed to 3.2 million new diabetes cases worldwide in 2016, or about 14 percent of all new cases ...
-
Assessment & Treatment of Five Diabetic Emergencies - Journal of Emergency Medical Services - JEMS.com
Posted: May 1st, 2018, 5:00am GMT
Assessment & Treatment of Five Diabetic Emergencies - Journal of Emergency Medical Services JEMS.comCommon emergencies encountered in diabetics are important due to both their frequency and that they're often life-threatening. The complications include 1) ...
-
Cell Transplant Helps Difficult Type 1 Diabetes - WebMD
Posted: March 30th, 2018, 5:00am GMT
Cell Transplant Helps Difficult Type 1 Diabetes WebMDSome people with type 1 diabetes develop a condition called hypoglycemia unawareness, which means they no longer feel symptoms when their blood sugar ...
-
Rare Tumor Could Help Produce Insulin For Type-1 Diabetics, Study Shows - CBS New York
Posted: February 20th, 2018, 6:00am GMT
Rare Tumor Could Help Produce Insulin For Type-1 Diabetics, Study Shows CBS New YorkNEW YORK (CBSNewYork) — Researchers have a found a surprising potential ally in the search for a cure for Type-1 diabetes. It's a rare tumor that produces a ...
-
I was a doctor prone to fainting. This is how I got over it - The Guardian
Posted: January 16th, 2018, 6:00am GMT
I was a doctor prone to fainting. This is how I got over it The GuardianMedicine is great, but it involves pain, pus and blood. For some, seeing those things is a problem. When I started medical school, I was worried. Before applying ...
-
Rare Tumors Provide Clues for Regenerating Beta Cells and Diabetes Therapy - Genetic Engineering & Biotechnology News
Posted: October 3rd, 2017, 5:00am GMT
Rare Tumors Provide Clues for Regenerating Beta Cells and Diabetes Therapy Genetic Engineering & Biotechnology NewsA type of benign pancreatic tumor has provided insights into the genes and pathways involved in beta-cell regeneration, as a starting point for developing new ...
-
Rare Tumors Provide Clues for Regenerating Beta Cells and Diabetes Therapy - Genetic Engineering & Biotechnology News
Posted: October 3rd, 2017, 5:00am GMT
Rare Tumors Provide Clues for Regenerating Beta Cells and Diabetes Therapy Genetic Engineering & Biotechnology NewsA type of benign pancreatic tumor has provided insights into the genes and pathways involved in beta-cell regeneration, as a starting point for developing new ...
-
Pancreatic Cancer Early Symptoms: Recognizing These Signs Of Silent Killer Could Save Your Life - Medical Daily
Posted: November 4th, 2016, 5:00am GMT
Pancreatic Cancer Early Symptoms: Recognizing These Signs Of Silent Killer Could Save Your Life Medical DailyWhat are the symptoms of pancreatic cancer? There are two types of this cancer; here is a list of symptoms for both.
-
Ferret Diseases, Part 2: Adrenal Gland Disease • Long Beach Post - Long Beach Post
Posted: September 13th, 2015, 5:00am GMT
Ferret Diseases, Part 2: Adrenal Gland Disease • Long Beach Post Long Beach PostNote: Though owning a ferret is illegal in California, it's legal to own a ferret in several states. Ownership is regulated in a few of them. The Long Beach Post is an ...
-
Gastroenteropancreatic neuroendocrine tumors: an interview with Dr. Alexandria Phan - News-Medical.net
Posted: October 22nd, 2014, 5:00am GMT
Gastroenteropancreatic neuroendocrine tumors: an interview with Dr. Alexandria Phan News-Medical.netGEP-NETs stands for gastroenteropancreatic (GEP) neuroendocrine tumors (NETs). This is a type of rare cancer that is increasing in incidence and prevalence ...
-
A Coma Was Her First Warning of Diabetes - Everyday Health
Posted: November 6th, 2012, 6:00am GMT
A Coma Was Her First Warning of Diabetes Everyday HealthThree years ago, Parla Mejia, 45, was two-and-a-half times the woman she is today. In 2009, she weighed 370 pounds. She was so overweight and unhealthy ...
-
Woman's postpartum depression was caused by a tumor - Fox News
Posted: October 25th, 2012, 5:00am GMT
Woman's postpartum depression was caused by a tumor Fox NewsFor a 34-year-old new mother in Massachusetts, what looked like a case of postpartum depression turned out to be odd behavior with a less obvious cause: a ...
-
Steve Jobs dead: A layman's guide to islet-cell tumors in the pancreas. - Slate Magazine
Posted: October 6th, 2011, 5:00am GMT
Steve Jobs dead: A layman's guide to islet-cell tumors in the pancreas. Slate MagazineApple co-founder Steve Jobs died on Wednesday at 56. Though his family has not announced the cause of Jobs' death, the AP reports that medical experts...
-
Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery - New England Journal of Medicine (subscription)
Posted: July 21st, 2005, 5:00am GMT
Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery New England Journal of Medicine (subscription)We describe six patients (five women and one man; median age, 47 years; range, 39 to 54) with postprandial symptoms of neuroglycopenia owing to ...